Ridgetech Inc. (RDGT)
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Last price
- $0.84
- As of
Kresmion compiles this page from RDGT's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Ridgetech Inc. (RDGT): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-09-09.
See the full RDGT dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for RDGT on one page. Preview it with sample data, then open it live with a free account.
Preview the RDGT dossierActive signals for RDGT
- mediumEARNINGS_BEAT
Q1-2011: Beat consensus by 11.1% - EPS $6120 vs $5508 estimate
- mediumEARNINGS_MISS
Q2-2011: Missed consensus by 30.8% - EPS $4320 vs $6242.4 estimate
- mediumEARNINGS_MISS
Q3-2011: Missed consensus by 9.9% - EPS $6120 vs $6793.2 estimate
- mediumEARNINGS_BEAT
Beat consensus by 11.1% - EPS $6120 vs $5508 estimate
- mediumEARNINGS_MISS
Missed consensus by 30.8% - EPS $4320 vs $6242.4 estimate
FREE, NO ACCOUNT
Every signal on RDGT, as it fires
You are seeing 5 of 6 signals recorded on RDGT since 2026-06-01.
The five above landed across 2 days. The other 1 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, RDGT
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 20-FSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
RDGT against its peers
RDGT's operating margin of -1.4% ranks in the 81st percentile of 7 Pharmaceutical Retailers sub-industry peers, fiscal periods ending between 2025-10-31 and 2026-03-31.
| Metric | RDGT | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 132M USD | 3.2M USD | 79 | 6 |
| Revenue YoY | 10.2% | n/a | n/a | 3 |
| Gross margin | 3.6% | 41.5% | 6 | 7 |
| Operating margin | -1.4% | -32.8% | 81 | 7 |
| Net margin | -0.9% | -32.7% | 81 | 7 |
| Return on equity | -3.1% | -59.2% | 75 | 5 |
Peers (8): PMHS, SCNX, POM, PETS, SHFH, BHIC, HITI, RTEZ. Left out: BLMH (no annual filing), DHTI (period gap), PNPL (period gap), TELYF (no annual filing). Fiscal periods ending between 2025-10-31 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (RDGT: 20-F), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow RDGT on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to RDGT for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.